Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122379) titled 'Clinical Comprehensive Evaluation on Weight-loss Drugs' on April 13.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shandong Provincial Hospital
Condition:
overweight or obesity
Intervention:
Orlistat group:none
Liraglutide group:none
Beinaglutide group:none
Semaglutide group:none
Tilporopeptide group:none
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-05-01
Target Sample Size: Orlistat group:100;Liraglutide group:100;Beinaglutide group:100;Semaglutide group:100;Tilporopeptide group:100;Mazdutide group:100;
Countries of Recruitment:
China
...